1 April 2024 false No description of principal activity Taxfiler 2024.6 14760845business:PrivateLimitedCompanyLtd2024-04-012025-03-31 147608452024-03-31 147608452024-04-012025-03-31 14760845business:AuditExempt-NoAccountantsReport2024-04-012025-03-31 14760845business:AbridgedAccounts2024-04-012025-03-31 147608452025-03-31 14760845business:Director12024-04-012025-03-31 14760845business:Director22024-04-012025-03-31 147608452024-03-31 14760845core:WithinOneYear2025-03-31 14760845core:WithinOneYear2024-03-31 14760845core:AfterOneYear2025-03-31 14760845core:AfterOneYear2024-03-31 14760845core:ShareCapitalcore:PreviouslyStatedAmount2025-03-31 14760845core:ShareCapitalcore:PreviouslyStatedAmount2024-03-31 14760845core:CapitalContributionReservecore:PreviouslyStatedAmount2025-03-31 14760845core:CapitalContributionReservecore:PreviouslyStatedAmount2024-03-31 14760845core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-03-31 14760845core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-03-31 14760845core:PreviouslyStatedAmount2025-03-31 14760845core:PreviouslyStatedAmount2024-03-31 14760845business:SmallEntities2024-04-012025-03-31 14760845countries:EnglandWales2024-04-012025-03-31 147608452023-03-272024-03-31 iso4217:GBP xbrli:pure
Company Registration No. 14760845 (England and Wales)
Bear Cross Pharma Ltd Unaudited accounts for the year ended 31 March 2025
Bear Cross Pharma Ltd Unaudited accounts Contents
Page
- 2 -
Bear Cross Pharma Ltd Company Information for the year ended 31 March 2025
Directors
Jean Okutu Antwi Isaac Ababio Antwi
Company Number
14760845 (England and Wales)
- 3 -
Bear Cross Pharma Ltd Statement of financial position as at 31 March 2025
2025 
2024 
Notes
£ 
£ 
Current assets
Debtors
90,732 
6,310 
Cash at bank and in hand
29,705 
7,347 
120,437 
13,657 
Creditors: amounts falling due within one year
- 
4,000 
Net current assets
120,437 
17,657 
Total assets less current liabilities
120,437 
17,657 
Creditors: amounts falling due after more than one year
144,477 
107,577 
Net assets
264,914 
125,234 
Capital and reserves
Called up share capital
108,117 
108,117 
Capital contribution reserve
373,417 
128,475 
Profit and loss account
(216,620)
(111,358)
Shareholders' funds
264,914 
125,234 
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the year in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 11 December 2025 and were signed on its behalf by
Jean Okutu Antwi Director Company Registration No. 14760845
- 4 -
Bear Cross Pharma Ltd Notes to the Accounts for the year ended 31 March 2025
1
Statutory information
Bear Cross Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 14760845.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 5 -